GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: Is there a correlation with clinical stage, gleason grade, PSA value or age?

European Journal of Medical Research

Volumn 9, Issue 11, 2004, Pages 523-527

  Bastian, Patrick J ^a,c   Ellinger, J ^b   Schmidt, D ^a   Wernert, N ^b   Wellmann, A ^b   Muller S C ^a   von Rucker A ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; CpG island hypermethylation; DNA methylation; GSTP1; Prostate cancer

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; ISOENZYME; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD; CLASSIFICATION; DNA METHYLATION; GENETICS; HUMAN; MALE; MIDDLE AGED; PROSTATE HYPERTROPHY; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; AGED; CELL LINE, TUMOR; DNA METHYLATION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 13844320790     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jemal A, Murry T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53: 5-26
2. Catalona WJ, Smith DS, Ratliff TL et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen based screening. JAMA 1993;270: 948-954
3. Mettlin C, Lee F, Drago J et al. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991;67: 2949-2958
4. Waaler G, Ludvigsen TC, Runden TO et al. Digital rectal examination to screen or prostatic cancer. Eur Urol 1988;15: 34-36
5. de Koning HJ and Schroeder FH. PSA screening for prostate cancer: the current controversy. Ann Oncol 1998;9: 1293-1296
6. Catalona WJ, Southwick PC, Slawin KM et al. Comparison of percent free PSA, PSA denisty and age-specific PSA cutoffs for prostate cancer detection and staging Urology 2000;56: 255-260
7. Baylin SB, Herman JG, Graff JR, Vertino P, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72, 141-6
8. Jones PA and Baylin SB. The fundamental role of epigenetiv events in cancer. Nature reviews genetics;3, 415-28
9. Mannervik B, Alin P, Guthenberg C et al. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad USA 1985;82, 7202-7206
10. Lee WH, Morton RA, Epstein JI et al, Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostati adeno-carcinogenesis. Proc Natl Acad Sci 1994;91: 11733-11737
11. Sakr, WA, Grignon, DJ, Crissman, JD et al.: High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo, 1994;8: 439-434
12. Etzioni R, Penson DF; Legler JM et al. Overdiagnosis due o prostate-specific antigen screening; lessons from U.S. prostate cancer incidencetreds. J Natl Cancer Inst 2002;94, 981-990
13. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001, 29, E65-5
14. Lee, WH, Isaacs, WB, Bova, GS, Nelson WG: CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 1997;6: 443-450
15. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova S, Epstein JI, Isaacs WB, Nelson WG. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998;7: 531-536
16. Jernimo C, Usadel H, Henrique R et al. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 2002;60: 1131-1135
17. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate. Implications for prostatic carcinogenesis. Am J Pathol 1999;155; 1985-1992
18. Nakayama M ,Bennett CJ, Hicks JL et al. Hypermethylation of the human glutathione s-transferase-π gene (GSTP1) CpG island is presenrin a subset of proliferative inflammatory atrophy but not in normal or hyperplastic epithelium of the prostate. Am J Pathol 2003;163: 923-933
19. Jeronimo C, Usadel H, Henrique R et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 2001;93: 1747-1752
20. Toyota M, Issa JP. CpG island methylator phenotypes in aging and cancer. Sem Cancer Biol 9: 349-57, 1999
21. Ahuja N, Li Q, Mohan AL et al. Aging, DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58: 5489-94
22. Ross SA. Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci 2003;983: 197-207
23. Yamanaka M, Watanabe K Yamada Y et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 2003;106: 382-387
24. Lin X, Tascilar M, Lee WH et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 2001;159:1815-1826
25. Watannabe M, Nakayama T, Shiraishi T et al. Comparative studies of proswe cancer in Japan versus the United States. A review. Urol Oncol 2000,5: 274-283
26. Woodson K, Hayes R, Wideroff , Villaruz L, Tangrea J. Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 2003,55: 199-205
27. Harden SV, Guo Z, Epstein JI, Sidransky D. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 2003;169: 1138-1142
28. Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG. Prostate cancer detection by GSTP1 methyladon analysis of post-biopsy urine specimens. Chn Cancer Res 2003;9: 2673-2677
29. Goessl C, Muller M, Straub B, Miller K. DNA alterations in body fluids as molecular tumor markers for urological malignancies. Eur Urol 2002;41: 668-676
30. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61: 3225-3229
31. Chu DC, Chuang CK, Fu JB, Huang HS, Tseng CP, Sun CF. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma. J Urol 2002;167: 1854-1858
32. Yegnasubramanian S, Kowalski J, Gonzalgo, ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Matzo AM, Isaacs WB, Nelson WG. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 2004; 6:1975-1986
33. Zhou M, Tokumaru Y, Sidransky D, Epstein JI. Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies. J Urol 2004:171; 2195-2198.
34. Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer. J Urol 2004: 172; 508-511.